ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000196756.7	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.032064608	Resistant
ENSG00000196756.7	ABT-263 (navitoclax)	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.02979346	Sensitive